{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:38:56Z","timestamp":1773693536503,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.bcp.2015.12.002","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T14:06:59Z","timestamp":1449929219000},"page":"132-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Knock-down of CIAPIN1 sensitizes K562 chronic myeloid leukemia cells to Imatinib by regulation of cell cycle and apoptosis-associated members via NF-\u03baB and ERK5 signaling pathway"],"prefix":"10.1016","volume":"99","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianxiang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.12.002_bib0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.12.002_bib0010","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.12.002_bib0015","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study","volume":"99","author":"Sawyers","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2015.12.002_bib0020","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1073\/pnas.92.7.2558","article-title":"Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class","volume":"92","author":"Buchdunger","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.12.002_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.12.002_bib0030","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.cdd.4400400","article-title":"Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR\u2fffABL tyrosine kinase, CGP 57148","volume":"5","author":"Dan","year":"1998","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2015.12.002_bib0035","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR\u2fffABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2015.12.002_bib0040","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","article-title":"Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation","volume":"99","author":"Holtz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2015.12.002_bib0045","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2fffBrien","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2015.12.002_bib0050","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMoa030513","article-title":"Frequency of major molecular responses to Imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia","volume":"349","author":"Hughes","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2015.12.002_bib0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1084\/jem.20031858","article-title":"Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis","volume":"199","author":"Shibayama","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2015.12.002_bib0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4161\/cbt.8.11.8795","article-title":"Inhibiting gastric cancer-associated angiogenesis by CIAPIN1 siRNA","volume":"8","author":"Yan","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2015.12.002_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijbiomac.2007.08.009","article-title":"Successful expression and purification of human CIAPIN1 in baculovirus-insect cell system and application of this system to investigation of its potential methyltransferase activity","volume":"42","author":"Hao","year":"2008","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2015.12.002_bib0070","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4161\/cbt.8.11.8796","article-title":"Downregulated expression of CIAPIN1 may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression","volume":"8","author":"Hao","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2015.12.002_bib0075","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/carcin\/bgn052","article-title":"Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo","volume":"29","author":"Li","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2015.12.002_bib0080","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.4161\/cbt.6.10.4684","article-title":"CIAPIN1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating CyclinD1 and upregulating P27","volume":"6","author":"Li","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2015.12.002_bib0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2008.10.044","article-title":"CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma","volume":"276","author":"He","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2015.12.002_bib0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10428190701713697","article-title":"The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients","volume":"49","author":"Shizusawa","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcp.2015.12.002_bib0095","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1139\/O07-141","article-title":"A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax","volume":"85","author":"Li","year":"2007","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2015.12.002_bib0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4161\/cbt.5.3.2381","article-title":"CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells","volume":"5","author":"Hao","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2015.12.002_bib0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2015.12.002_bib0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0145-2126(94)90103-1","article-title":"Leukemia cell lines: in vitro models for the study of chronic myeloid leukemia","volume":"18","author":"Drexler","year":"1994","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcp.2015.12.002_bib0115","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.yexcr.2011.05.026","article-title":"NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP","volume":"317","author":"Lin","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2015.12.002_bib0120","first-page":"167","article-title":"Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy","volume":"2010","author":"Li","year":"1805","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2015.12.002_bib0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1517\/14728222.2010.522570","article-title":"NF-kappaB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia","volume":"14","author":"Breccia","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bcp.2015.12.002_bib0130","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/sj.leu.2402641","article-title":"Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts","volume":"16","author":"Baumgartner","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2015.12.002_bib0135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.24294","article-title":"NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr\u2fffAbl mutants","volume":"125","author":"Lounnas","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2015.12.002_bib0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2008.07.003","article-title":"New insights into NF-kappaB regulation and function","volume":"29","author":"Sun","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcp.2015.12.002_bib0145","first-page":"1013","article-title":"Chromosome studies in human leukemia. II. Chronic granulocytic leukemia","volume":"27","author":"Nowell","year":"1961","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcp.2015.12.002_bib0150","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bcp.2015.12.002_bib0155","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.leu.2402912","article-title":"Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies","volume":"17","author":"Clarkson","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2015.12.002_bib0160","first-page":"152","article-title":"Chronic myeloid leukemia in 2006: a perspective","volume":"91","author":"Mauro","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2015.12.002_bib0165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2015.12.002_bib0170","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V99.6.1928","article-title":"Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study","volume":"99","author":"Talpaz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2015.12.002_bib0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2015.12.002_bib0180","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR\u2fffABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2015.12.002_bib0185","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2015.12.002_bib0190","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.3390\/molecules17067595","article-title":"Down regulation of CIAPIN1 reverses multidrug resistance in human breast cancer cells by inhibiting MDR1","volume":"17","author":"Lu","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2015.12.002_bib0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/156720213804805909","article-title":"CIAPIN1 siRNA inhibits proliferation, migration and promotes apoptosis of VSMCs by regulating Bcl-2 and Bax","volume":"10","author":"Yang","year":"2013","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.bcp.2015.12.002_bib0200","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.12.7.968","article-title":"A requirement for NF-kappaB activation in Bcr\u2fffAbl-mediated transformation","volume":"12","author":"Reuther","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2015.12.002_bib0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0301-472X(03)00069-9","article-title":"Mechanisms of Bcr-Abl-mediated NF-kappaB\/Rel activation","volume":"31","author":"Kirchner","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcp.2015.12.002_bib0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.leu.2403998","article-title":"The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance","volume":"20","author":"Cilloni","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2015.12.002_bib0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728220903431069","article-title":"The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy","volume":"14","author":"Lin","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bcp.2015.12.002_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevOncog.v15.i1-2.10","article-title":"Nuclear factor-kappaB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia","volume":"15","author":"Reikvam","year":"2009","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.bcp.2015.12.002_bib0225","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.leukres.2014.06.013","article-title":"CIAPIN1 targets Na+\/H+ exchanger 1 to mediate K562 chronic myeloid leukemia cells\u2fff differentiation via ERK1\/2 signaling pathway","volume":"38","author":"Wang","year":"2014","journal-title":"Leuk. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215007571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215007571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:25:09Z","timestamp":1748719509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215007571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":45,"alternative-id":["S0006295215007571"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.12.002","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knock-down of CIAPIN1 sensitizes K562 chronic myeloid leukemia cells to Imatinib by regulation of cell cycle and apoptosis-associated members via NF-\u03baB and ERK5 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}